Initiation of Plasminogen Activation on the Surface of Monocytes Expressing the Type II Transmembrane Serine Protease Matriptase
Overview
Authors
Affiliations
uPA (urokinase-type plasminogen activator) activates plasminogen with high efficiency when bound to its cellular receptor uPAR, but only after a prolonged lag phase during which generated plasmin activates pro-uPA. How the activity of this proteolytic system might be rapidly initiated is unknown. We have now found that 2 monocytic cell lines display distinct patterns of plasminogen activation. U937 cells, but not THP-1 cells, displayed the expected lag phase, suggesting a constitutive initiation mechanism on the latter. This was shown to be due to the plasmin-independent activation of uPAR-bound pro-uPA by a cell surface-associated protease and to correlate with the expression of matriptase, a type II transmembrane serine protease that was highly expressed in THP-1 cells but undetectable in U937 cells. Kinetic analysis demonstrated that matriptase is a relatively poor activator of pro-uPA in solution, approximately 100-fold less efficient than plasmin (k(cat)/K(m) 1.16 x 10(5) M(-1)s(-1) cf 1.21 x 10(7) M(-1)s(-1)). However, down-regulation of matriptase expression in THP-1 cells by siRNA reduced the activation of cell-associated pro-uPA and the subsequent rapid initiation of plasminogen activation by 76% to 93%. Matriptase was also found to be expressed by peripheral blood monocytes and may therefore be a specific mechanism for the rapid initiation and regulation of plasminogen activation by these cells.
Buzza M, Pawar N, Strong A, Antalis T Int J Mol Sci. 2023; 24(11).
PMID: 37298257 PMC: 10252689. DOI: 10.3390/ijms24119306.
Chlastakova A, Kascakova B, Kotal J, Langhansova H, Kotsyfakis M, Kuta Smatanova I Front Immunol. 2023; 14:1116324.
PMID: 36756125 PMC: 9901544. DOI: 10.3389/fimmu.2023.1116324.
Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19.
Shmakova A, Popov V, Romanov I, Khabibullin N, Sabitova N, Karpukhina A Int J Mol Sci. 2023; 24(2).
PMID: 36674896 PMC: 9867169. DOI: 10.3390/ijms24021382.
The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells.
Steiro I, Vandsemb E, Elsaadi S, Misund K, Sponaas A, Borset M Oncotarget. 2022; 13:1175-1186.
PMID: 36268559 PMC: 9584456. DOI: 10.18632/oncotarget.28300.
Izumi A, Yamamoto K, Kawaguchi M, Yamashita F, Fukushima T, Kiwaki T Cancer Sci. 2022; 113(6):2179-2193.
PMID: 35332604 PMC: 9207362. DOI: 10.1111/cas.15346.